Kurs & Likviditet
Kalender
2024-08-07 | Kvartalsrapport 2024-Q2 |
2024-06-06 | Ordinarie utdelning BIOBV 0.00 EUR |
2024-06-05 | Årsstämma 2024 |
2024-02-14 | Bokslutskommuniké 2023 |
2023-08-09 | Kvartalsrapport 2023-Q2 |
2023-06-15 | Ordinarie utdelning BIOBV 0.00 EUR |
2023-06-14 | Årsstämma 2023 |
2023-03-22 | Bokslutskommuniké 2022 |
2022-08-10 | Kvartalsrapport 2022-Q2 |
2022-06-16 | Ordinarie utdelning BIOBV 0.00 EUR |
2022-06-15 | Årsstämma 2022 |
2022-03-09 | Extra Bolagsstämma 2022 |
2022-02-16 | Bokslutskommuniké 2021 |
2021-08-11 | Kvartalsrapport 2021-Q2 |
2021-04-22 | Ordinarie utdelning BIOBV 0.00 EUR |
2021-04-21 | Årsstämma 2021 |
2021-02-17 | Bokslutskommuniké 2020 |
2020-08-12 | Kvartalsrapport 2020-Q2 |
2020-04-23 | Ordinarie utdelning BIOBV 0.00 EUR |
2020-04-22 | Årsstämma 2020 |
2020-02-19 | Bokslutskommuniké 2019 |
2019-08-14 | Kvartalsrapport 2019-Q2 |
2019-04-25 | Ordinarie utdelning BIOBV 0.00 EUR |
2019-04-24 | Årsstämma 2019 |
2019-02-20 | Bokslutskommuniké 2018 |
2018-08-22 | Kvartalsrapport 2018-Q2 |
2018-08-16 | Extra Bolagsstämma 2018 |
2018-04-26 | Ordinarie utdelning BIOBV 0.00 EUR |
2018-04-25 | Årsstämma 2018 |
2018-02-28 | Bokslutskommuniké 2017 |
2017-07-27 | Kvartalsrapport 2017-Q2 |
2017-04-27 | Ordinarie utdelning BIOBV 0.00 EUR |
2017-04-26 | Årsstämma 2017 |
2017-02-02 | Bokslutskommuniké 2016 |
2016-10-20 | 15-10 2016-Q3 |
2016-08-10 | Kvartalsrapport 2016-Q2 |
2016-05-12 | Kvartalsrapport 2016-Q1 |
2016-04-26 | Ordinarie utdelning BIOBV 0.00 EUR |
2016-04-25 | Årsstämma 2016 |
2016-02-25 | Bokslutskommuniké 2015 |
2015-10-22 | Kvartalsrapport 2015-Q3 |
2015-08-20 | Kvartalsrapport 2015-Q2 |
2015-05-07 | Kvartalsrapport 2015-Q1 |
2015-04-21 | Ordinarie utdelning BIOBV 0.00 EUR |
2015-04-20 | Årsstämma 2015 |
2015-02-26 | Bokslutskommuniké 2014 |
2014-10-23 | Kvartalsrapport 2014-Q3 |
2014-08-21 | Kvartalsrapport 2014-Q2 |
2014-05-08 | Kvartalsrapport 2014-Q1 |
2014-04-15 | Ordinarie utdelning BIOBV 0.72 EUR |
2014-04-14 | Årsstämma 2014 |
2014-02-27 | Bokslutskommuniké 2013 |
2013-10-24 | Kvartalsrapport 2013-Q3 |
2013-08-08 | Kvartalsrapport 2013-Q2 |
2013-04-25 | Kvartalsrapport 2013-Q1 |
2013-04-09 | Ordinarie utdelning BIOBV 0.50 EUR |
2013-04-08 | Årsstämma 2013 |
2013-02-27 | Bokslutskommuniké 2012 |
2012-10-25 | Kvartalsrapport 2012-Q3 |
2012-08-16 | Kvartalsrapport 2012-Q2 |
2012-04-26 | Kvartalsrapport 2012-Q1 |
2012-04-12 | Ordinarie utdelning BIOBV 1.00 EUR |
2012-04-11 | Årsstämma 2012 |
2012-02-29 | Bokslutskommuniké 2011 |
2011-11-23 | Extra Bolagsstämma 2011 |
2011-10-20 | Kvartalsrapport 2011-Q3 |
2011-08-18 | Kvartalsrapport 2011-Q2 |
2011-04-28 | Kvartalsrapport 2011-Q1 |
2011-04-14 | Ordinarie utdelning BIOBV 0.00 EUR |
2011-04-13 | Årsstämma 2011 |
2011-03-01 | Bokslutskommuniké 2010 |
2010-04-26 | Ordinarie utdelning BIOBV 0.00 EUR |
2009-04-21 | Ordinarie utdelning BIOBV 0.00 EUR |
2008-04-22 | Ordinarie utdelning BIOBV 0.00 EUR |
2007-04-20 | Ordinarie utdelning BIOBV 0.00 EUR |
2006-04-21 | Ordinarie utdelning BIOBV 0.00 EUR |
2005-04-22 | Ordinarie utdelning BIOBV 0.00 EUR |
2004-04-16 | Ordinarie utdelning BIOBV 0.00 EUR |
2003-04-10 | Ordinarie utdelning BIOBV 0.00 EUR |
2002-04-02 | Ordinarie utdelning BIOBV 0.00 EUR |
2001-03-28 | Ordinarie utdelning BIOBV 0.00 EUR |
2000-04-07 | Ordinarie utdelning BIOBV 0.00 EUR |
1999-04-22 | Ordinarie utdelning BIOBV 0.00 EUR |
Beskrivning
Land | Finland |
---|---|
Lista | Small Cap Helsinki |
Sektor | Hälsovård |
Industri | Medicinteknik |
Biohit Plc Stock Exchange Release March 27, 2024 at 9:30 a.m. (EEST)
A total number of 60,000 new Biohit Plc B-shares have been subscribed for with stock options I 2021B and stock options I 2022B between 1 March 2024 and 11 Mach 2024. These shares have been entered into the Trade Register on March 27, 2024, as of which date the new shares will establish equal shareholder rights with the company's existing B-shares. Public trading begins on Nasdaq Helsinki Ltd as of March 28, 2024 together with the existing B-shares.
The share subscription price was EUR 1.00 per share respectively. The entire subscription price of EUR 60,000 will be credited to the reserve for invested non-restricted equity, and the company share capital remains unchanged. The shares have no nominal value.
After the subscriptions the number of all Biohit Plc's shares will rise to 15,173,593 shares and B-shares will rise to 12,198,093 shares.
The share subscription period with stock options I 2021B began on March 1, 2024 and ends on March 1, 2028. The option scheme is based on the Biohit Plc board resolution of February 9, 2021 and the Annual General Meeting authorization of September 16, 2020.
The share subscription period with stock options I 2022B began on March 1, 2024 and ends on March 1, 2028. The option scheme is based on the Biohit Plc board resolution of November 29, 2022 and the Annual General Meeting authorization of June 15, 2022.
The terms and conditions of the option schemes with additional information are available on Biohit Plc website at www.biohithealthcare.com.
Additional information:
Biohit Plc
CEO Jussi Hahtela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com